There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

Revenue: €2.07b (down 1.1% from FY 2023). Net income: €178.7m (down 39% from FY 2023). Profit margin: 8.7% (down from 14% in ...

European shares rallied to be in positive territory after a weak start on Wednesday as traders eyed corporate updates and also turned their attention to US inflation data later in the day.

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology ...

European stocks eased further from multi-week highs on Wednesday after a series of downbeat corporate updates and as ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ZEISS Research Microscopy Solutions and AI pathology leader Mindpeak have joined forces to develop an integrated Multiplex ...

With a low-teens market share, Zeiss is the second-largest player in the industry. We expect the segment to grow at a mid-single-digit rate over the next five years driven by an aging population, an ...

Emanuel Goldberg In the 1920s the German scientist Emanuel Goldberg of Zeiss Ikon (see the Knowledge Machine of Emanuel ...